FDA Dietary Supplements Comment

TINA.org submitted a comment to the FDA regarding supplement marketers’ use of unsubstantiated disease-treatment claims and urging the agency to do more to protect susceptible populations, including the elderly.


How We Took Action

May 16, 2019: TINA.org’s Executive Director provides comment to the FDA at its public meeting on Responsible Innovation in Dietary Supplements.


Featured

Comment at FDA Public Meeting on Dietary Supplements

Blog

Comment at FDA Public Meeting on Dietary Supplements

Comment made by TINA.org executive director, Bonnie Patten at the FDA’s public meeting on Responsible Innovation in Dietary Supplements held on May 16, 2019. Thank you for the opportunity to…